Karin Roberg
Overview
Explore the profile of Karin Roberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
46
Citations
1056
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Talani C, Olsson H, Roberg K, Wiechec E, Almangush A, Makitie A, et al.
Cancers (Basel)
. 2025 Jan;
17(2).
PMID: 39858084
The aim of this study was to evaluate biomarkers and biological characteristics of tumor biopsies from patients with head and neck cancer (HNC) to assess the risk of early death....
2.
Rademaekers M, Johansson E, Johansson E, Roberg K, Wiechec E
Cancer Cell Int
. 2024 May;
24(1):190.
PMID: 38822309
Background: Cancer-associated fibroblasts (CAFs) are the major cellular component of the tumor microenvironment and are known to affect tumor growth and response to various treatments. This study was undertaken to...
3.
Ajan A, Roberg K, Fredriksson I, Abtahi J
Microvasc Res
. 2024 Feb;
153:104666.
PMID: 38301938
Objectives: Laser Doppler Flowmetry (LDF) is a non-invasive technique for the assessment of tissue blood flow, but increased reproducibility would facilitate longitudinal studies. The aim of the study was to...
4.
Matic N, Pettersson L, Sellebjerg F, Lindberg L, Roberg K, Wiechec E
Transl Oncol
. 2023 Nov;
39:101841.
PMID: 38016355
Head and neck squamous cell carcinoma (HNSCC) is a disease associated with a severe mortality and high risk of distant metastasis and local recurrence. Currently, surgery and radiotherapy are the...
5.
Zhu G, Azharuddin M, Pramanik B, Roberg K, Biswas S, Darcy P, et al.
ACS Appl Mater Interfaces
. 2023 Mar;
15(14):17485-17494.
PMID: 36976817
Despite the enormous advancements in nanomedicine research, a limited number of nanoformulations are available on the market, and few have been translated to clinics. An easily scalable, sustainable, and cost-effective...
6.
Wiechec E, Matic N, Ali A, Roberg K
Oncol Rep
. 2022 Jan;
47(3).
PMID: 35059742
Hypoxia has been linked with increased resistance to treatment in various solid tumors, including head and neck squamous cell carcinoma (HNSCC). The aim of the present study was to identify...
7.
Wiechec E, Magan M, Matic N, Ansell-Schultz A, Kankainen M, Monni O, et al.
Cancers (Basel)
. 2021 Jul;
13(13).
PMID: 34283070
Cancer-associated fibroblasts (CAFs) are known to increase tumor growth and to stimulate invasion and metastasis. Increasing evidence suggests that CAFs mediate response to various treatments. HNSCC cell lines were co-cultured...
8.
Zhang X, Wang C, Feng G, Jiang J, Hu J, du Rietz A, et al.
Small
. 2021 Jun;
17(31):e2101440.
PMID: 34173333
Given the breadth of currently arising opportunities and concerns associated with nanoparticles for biomedical imaging, various types of nanoparticles have been widely exploited, especially for cellular/subcellular level probing. However, most...
9.
Magan M, Wiechec E, Roberg K
Cancer Cell Int
. 2020 Dec;
20(1):599.
PMID: 33353547
Background: Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous group of tumors for which the overall survival rate worldwide is around 60%. The tumor microenvironment, including cancer-associated fibroblasts...
10.
Azharuddin M, Roberg K, Dhara A, Jain M, Darcy P, Hinkula J, et al.
Sci Rep
. 2019 Dec;
9(1):20066.
PMID: 31882620
One of the hallmarks of cancers is their ability to develop resistance against therapeutic agents. Therefore, developing effective in vitro strategies to identify drug resistance remains of paramount importance for...